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Thirty female Large White £ Landrace pigs (average weight 57·2 (SD 1·9) kg) were allocated to
one of six dietary treatments containing 0, 1·25, 2·5, 5·0, 7·5 or 10·0 g 55 % conjugated linoleic
acids (CLA) isomers (CLA-55)/kg diet and fed for 8 weeks. Each pig was scanned at 0, 28 and
56 d and again at post slaughter using dual-energy X-ray absorptiometry (DXA) to determine
the temporal pattern of body composition responses. Values determined by DXA were adjusted
using regression equations generated from validation experiments between chemically and
DXA-predicted values. Overall, there was a significant linear reduction in fat content with
the increasing levels of CLA in the diet (P¼0·007, P¼0·011, P¼0·008 at week 4, week 8
and for the carcass, respectively). The greatest improvement was recorded at the early stages
of CLA supplementation and for the highest dose of CLA (week 4, 219·2 % compared with
week 8, 213·7 %). In the first 4 weeks of feeding CLA, pigs receiving 10 g CLA-55/kg diet
deposited 93 g less fat/d than pigs fed basal diets (P¼0·002) compared with only 6 g less fat
than control animals in the final 4 weeks. Lean content and lean deposition rate were maximised
at 5 and 2·5 g CLA-55/kg diet for the first 4 weeks (P¼0·016) and the final 4 weeks of treatment
ðP ¼ 0·17Þ; respectively. DXA estimates of bone mineral content and bone mineral density
were not affected by CLA supplementation throughout the experiment. These data demonstrate
that dietary CLA decreases body fat in a dose-dependent manner and that the response is great-
est over the initial 4 weeks of treatment.
Conjugated linoleic acid: Dual-energy X-ray absorptiometry: Body composition: Pig
Conjugated linoleic acid (CLA) represents a mixture of
positional and geometric isomers (18 : 2n-6) of linoleic
acid with conjugated double bonds located at positions
7,9-, 8,10-, 9,11-, 10,12- or 11,13- on the C chain. CLA
exerts many positive health effects in experimental
models including anticarcinogenic and anti-tumorogenic
as well as anti-atherogenic and antidiabetogenic properties
(for reviews, see Whigham et al. 2000; Pariza et al. 2001).
Another biological effect of CLA relates to fat accretion
and nutrient partitioning. Dietary CLA supplementation
reduces body fat mass in rodents (Chin et al. 1994; Park
et al. 1995; DeLany et al. 1999) and pigs (Ostrowska
et al. 1999). These findings were based on experiments
involving slaughter and subsequent chemical analysis in
which the ultimate rates of change in body composition
were determined at the conclusion of CLA supplemen-
tation. However, little is known about the longitudinal
effects of CLA supplementation on body composition
and generation of such data requires killing large numbers
of animals at various stages of development. Alternatively,
body composition can be measured in live animals and
carcasses using dual-energy X-ray absorptiometry (DXA)
(Mitchell et al. 1998; Lukaski et al. 1999; Suster et al.
2000), which is non-invasive and allows longitudinal
studies in the same animal. The DXA apparatus can be
used to analyse the fat, lean and bone mineral content
(BMC) of the whole animal and is also capable of measur-
ing the regional distribution of these tissues (Mitchell et al.
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1996; Suster et al. 2001). The aim of the present study was
to utilise DXA technology to validate the effectiveness of
CLA supplementation in pigs and to generate more com-
prehensive data on the progressive change in body compo-
sition in growing and finisher pigs fed different levels of
dietary CLA.
Materials and methods
Animals and handling
All procedures involving animals were approved by the
Victorian Institute of Animal Science Animal Ethics
Committee (Anonymous, 1997). Thirty-five (Large
White £ Landrace) pigs were used in the experiment. To
obtain initial body composition by chemical analysis, five
pigs were killed (after an in vivo DXA scan; see p. 220)
at the beginning of the experiment. The remaining thirty
pigs were randomly allocated to one of six dietary treat-
ments (0, 1·25, 2·5, 5·0, 7·5 or 10·0 g CLA-55/kg diet
(Natural Lipids Ltd., Hovdebygda, Norway). The CLA
used in the present study contained 55 % (w/w) CLA
isomers and was prepared from sunflower-seed oil. There-
fore, the CLA concentrations for the six diets were 0, 0·7,
1·4, 2·75, 4·1 and 5·5 g/kg diet, respectively. The CLA con-
tent of the supplement and diets was measured by HPLC
(Cross et al. 2000; Ostrowska et al. 2000). The CLA-55
mixture consisted of 13·8 % trans/cis-8,10, 24·5 % cis/
trans-9,11, 30·5 % trans/cis-10,12 and 18·3 % cis/trans-
11,3 isomers present in a non-esterified fatty acid form.
The remainder of the CLA-55 mixture consisted of small
amounts of cis, cis and trans, trans isomers.
Pigs were initially blocked into groups of six pigs with an
average live weight of 57·2 (SD 1·9) kg and P2 back fat
(65 mm from the midline over the last rib) thickness of
11·5 (SD 1·3) mm. The experimental diets (Table 1) were
formulated to contain 14·3 MJ digestible energy, 9·3 g
lysine and 175 g crude protein/kg air-dry diet, which was
in excess of protein and lysine requirements for the class
of pig used in the study (Dunshea et al. 1993). Amino
acid content relative to lysine was kept in excess of the
amino acid balance proposed as ideal by the Standing
Committee on Agriculture (1987) to ensure that lysine
was the first limiting amino acid. Diets were fed ad libitum
for 8 weeks and unlimited access to water was provided via
nipple drinkers. Pigs were individually housed to allow
individual feed intake and live-weight measurements to be
made weekly.
Dual-energy X-ray absorptiometry scans
Total whole body DXA scans were performed using a
Hologic QDR 4500A Fan Beam X-Ray Bone Densitometer
(Hologic, Inc., Waltham, MA) equipped with the body
composition option software. The software calculates the
ratio of soft tissue attenuation (RST) of the low- and
high-energy beams as they pass through the body. The
attenuations of pure fat (RF) and of bone-free lean tissue
(RL) are known from theoretical calculation and in vitro
measurements. Thus, an equation for each X-ray energy
level with two unknown factors can be solved to calculate
the proportion of fat (1) and lean tissue (b) in each pixel
containing soft tissue only (Hologic, Inc.):
RST ðlow energyÞ ¼ 1ðRFÞ þ bðRLÞ;
RST ðhigh energyÞ ¼ 1ðRFÞ þ bðRLÞ:
On each scanning day, the unit was calibrated according
to the manufacturer’s specifications to ensure accurate fat
and lean composition results, for accurate BMC measure-
ment and to minimise baseline drift. Pigs were scanned
at the beginning of the experiment, after 4 weeks and
again at the conclusion of the experiment (after 8
weeks). Pigs were fasted for 16 h before scanning to mini-
mise errors associated with water in the gut lumen. Fasted
pigs were also weighed before scanning to assist with unit
calibration.
Table 1. Composition of experimental diets (g/kg)*
Dose of CLA-55 (g/kg diet)
Ingredients 0 1·25 2·5 5·0 7·5 10·0
Wheat 691·74 691·74 691·74 691·74 691·74 691·74
Soyabean meal 121·61 121·61 121·61 121·61 121·61 121·61
Peas 100·00 100·00 100·00 100·00 100·00 100·00
Dicalcium phosphate 26·71 26·71 26·71 26·71 26·71 26·71
Blood meal 21·12 21·12 21·12 21·12 21·12 21·12
Limestone 10·90 10·90 10·90 10·90 10·90 10·90
L-lysine hydrochloride 2·00 2·00 2·00 2·00 2·00 2·00
NaCl 2·00 2·00 2·00 2·00 2·00 2·00
Vitamin and mineral premix† 2·00 2·00 2·00 2·00 2·00 2·00
DL-methionine 0·98 0·98 0·98 0·98 0·98 0·98
L-threonine 0·94 0·94 0·94 0·94 0·94 0·94
Soyabean oil 20·0 18·75 17·5 15·0 12·5 10·0
CLA-55 0·0 1·25 2·5 5·0 7·5 10·0
CLA-55, 55 % conjugated linoleic acid.
* The wheat-based diet was formulated to contain 14·3 MJ digestible energy and 175 g crude protein/kg air-dry
diet.
† Provided the following nutrients (mg/kg air-dry diet: retinol, 6·4; cholecalciferol, 0·083; a-tocopherol, 22; mena-
dione, 0·60; riboflavin, 3·3; nicotinic acid, 16·5; pantothenic acid, 5·5; pyrodoxine, 1·1; biotin, 0·56; choline,
1100; cyanocobalamin, 0·017; Fe, 88; Zn, 55; Mn, 22; Cu, 6·6; I, 0·22; Se, 0·1.
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Pigs were anaesthetised using an intra-muscular injection
of Xylazine (20 mg Xylazine as hydrochloride/ml; Troy
Labs Pty. Ltd., Smithfield, NSW) and Ketamine (100 mg
Ketamine as hydrochloride/ml; Troy Labs Pty. Ltd.) at
0·05 and 0·1 ml/kg body weight, respectively. This intra-
muscular injection was followed by respiratory adminis-
tration of Isoflourane (Abbott Aust. Pty. Ltd., Kurmel,
NSW) to eliminate any further movement. For the final
scan before slaughter, Thiopentone (10 % Thiopentone
Sodium; Jorox Pty. Ltd., Silverwater, NSW) was adminis-
tered intravenously at 0·7 ml/kg body weight in place of
Ketamine and Xylazine. Sedated animals were placed
prone on the scan table, on their stomach with front and
back legs extended caudally. This orientation was used to
accommodate the DXA software, which was designed on
a basis of a laterally recumbent human subject, i.e. lying
on his or her back. Small plastic air-filled bags, undetectable
by DXA, were placed between the body and front legs to
provide the clearance required by the software to perform
accurate analysis.
Slaughter and carcass dual-energy X-ray absorptiometry
scans
After CO2 anaesthesia induced using a commercial CO2
stunning unit, pigs were exsanguinated, had hair removed
and were eviscerated. Internal organs were weighed and
the gastrointestinal tract emptied and reweighed. Internal
organs and empty gastrointestinal tract were then frozen at
2208C for analysis of fat, water and protein content. Car-
casses were hung in the chiller from the hindlimbs, and
had their front legs tied towards the dorsal end before the
onset of rigor. This allowed the correct body positioning
required for DXA scanning of carcasses, which was carried
out 24 h post chilling. The carcasses were wrapped in plastic
to minimise any moisture loss. Post scanning, the empty car-
casses were hung overnight at 48C before being split down
the midline and frozen. After freezing, the right side of each
carcass and the empty viscera were ground up separately
and prepared for chemical analyses (Campbell et al.
1985). DM and tissue moisture was determined by drying
samples to constant weight in a force-draught oven at
1058C. Ash was determined by combustion in a muffle fur-
nace at 6008C for 5 h. Protein was determined by Kjeldahl
analysis as modified by Helrich (1990) and fat was extracted
from freeze-dried samples by chloroform-methanol (2:1, v/v)
extraction (Folch et al. 1957). Lean tissue was determined
from the summation of tissue protein and water. Both
halves of the carcass were assumed to be equal in weight
and chemical composition and the results were doubled
for whole carcass estimation.
Calculation and statistical analysis
The DXA values obtained in the present study were
corrected using regression equations obtained from a
larger study involving 150 pigs ranging from 10 to
130 kg live weight and also scanned using the Hologic
QDR4500 DXA (Suster et al. 2000).
The effects of different levels of CLA in the diet on
body composition were analysed by ANOVA suitable for
a dose response with linear and quadratic effects deter-
mined. The model included block, replicate and CLA
dose. In addition, comparisons were made between diets
with or without CLA. For these analyses the model
included block and CLA dose. All analyses were per-
formed using GENSTAT for Windows, version 4.1
(Payne et al. 1993).
Results
Dietary CLA had no significant effect on average daily gain
throughout the present study (Table 2). However, in general
there was a linear reduction (P¼0·04) in feed intake with
increasing dose of CLA. This reduction in feed intake was
more pronounced over the first 4 weeks of treatment,
although a trend towards a linear reduction in feed intake
was still evident between weeks 4 and 8 (P¼0·09). Conse-
quently, feed conversion efficiency (FCE) was increased by
dietary CLA, particularly over the first 4 weeks of the treat-
ment. During the initial 4 weeks of the study there was a
quadratic (P¼0·03) increase in FCE with the effect maxi-
mised at 5 g CLA-55/kg diet. When all CLA treatments
were pooled, including CLA in the diet increased FCE by
8·1 % (P¼0·006) over the first 4 weeks while there was
no significant change between weeks 4 and 8 (P¼0·26).
While live weight at the end of the experiment was
unaffected by CLA supplementation, carcass weight
increased in a quadratic fashion with the highest carcass
weights being observed in pigs fed 5 g CLA-55/kg diet
(83·8 v. 86·6 kg for pigs fed diets supplemented with
0 and 5 g/kg, respectively; P¼0·006) (Table 3). Dressing
percentage was not affected by the CLA supplementation
(Table 3).
Appropriate blocking and allocation to treatments
ensured that there were no significant differences in DXA-
derived estimates of fat, lean, BMC and bone density at
the beginning of the experiment (data not shown). The
whole-body fat content of pigs fed diets supplemented
with CLA decreased in a linear fashion (P¼0·007 and
P¼0·01 at weeks 4 and 8, respectively) with increasing
level of dietary CLA (Table 4). The proportional reduction
in fat content was greatest at week 4, where in general,
CLA-fed pigs tended to have 10·3 % (P¼0·09) less fat
than the pigs fed the control diets (Table 4). At the highest
level of supplementation (10 g CLA-55/kg) a 19 % reduction
in body fat was observed (17·4 v. 14·1 kg; P¼0·007). After 8
weeks of CLA supplementation, a smaller (26 %) reduction
in body fat was still evident in CLA-fed pigs but this was not
significant (P¼0·32). Again, the greatest improvement was
observed at the highest level of supplementation with CLA-
55 (214 %). Significantly linear dose-dependent reductions
in fat mass (P¼0·008) were also observed in the carcass at
the end of the study (Table 4).
Dietary CLA supplementation increased DXA-deter-
mined lean tissue composition in a quadratic manner
throughout the entire experiment (P¼0·005 and P¼0·01
at weeks 4 and 8, respectively) (Table 4). After 4 weeks
of treatment, the lean tissue response was maximised in
pigs fed diets supplemented with 5 g CLA-55/kg (56·2 v.
58·6 kg). After 8 weeks of feeding, the effect was still
maximised at a CLA-55 level around 2·5 to 5·0 g/kg
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(67·4 v. 70·7 kg). The lean tissue composition in pigs fed
higher levels (.5 g/kg) of CLA-55 was not significantly
different from the control pigs. A similar quadratic
response (P¼0·009) was also observed for DXA-predicted
lean content of the carcass (Table 4). There was no signifi-
cant effect of dietary CLA supplement on DXA-deter-
mined empty body and carcass ash content (Table 4).
As expected from the DXA-predicted body composition
data, CLA supplementation caused a significant overall
linear decrease (P¼0·008) in the rate of fat deposition
(Table 5). When pooled across dietary treatments, pigs
fed CLA deposited 14·5 % less fat than control pigs over
the initial period of 4 weeks of supplementation (311 v.
266 g/d for control pigs; P¼0·07). The greatest reduction
in fat deposition was observed in pigs fed the highest
level of CLA (10 g CLA-55/kg diet) with a 30 % reduction
in fat deposition relative to controls (311 v. 218 g/d for
control pigs). The efficacy of CLA in reducing fat depo-
sition diminished during the final 4 weeks of feeding,
where pigs fed CLA were not different to the control
pigs (287 v. 299 g/d for control pigs; P¼0·59). However,
the combination of the large reduction in fat deposition
in the first 4 weeks of feeding, followed by little change
over the final 4 weeks, still resulted in an overall significant
(P¼0·008) linear reduction in fat deposition in pigs with
increasing levels of dietary CLA supplementation over
the duration of the experiment.
Over the initial 4 weeks of feeding, the DXA-estimated
lean deposition response to CLA supplementation was
quadratic (P¼0·02) in nature, being maximised at a dietary
CLA inclusion rate of 5·0 g CLA-55/kg (Table 5). However,
lean deposition rate during the final 4 weeks of treatment,
pooled across CLA-supplemented pigs, was no different
from control pigs (400 v. 420 g/d; P¼0·77) with no evidence
of a dose response. The magnitude of the response over the
first 4 weeks was such that lean deposition rate increased in
a quadratic manner (P¼0·017) over the entire duration of
the experiment, being maximised at a dietary CLA-55
inclusion of between 2·5 and 5 g/kg (Table 5).
The estimates of ash (Table 4) and bone mineral density
(data not shown) in live animals and carcasses, as deter-
mined by DXA, were largely unaffected by CLA
Table 3. Effect of dietary conjugated linoleic acid (CLA) on live
weight, carcass weight and dressing at the completion of the study*
(Mean values and standard effors of the difference)
Live weight
(kg)
Carcass
(kg)
Dressing
(g/kg)
Dose of CLA-55 (g/kg diet)†
0 104·8 83·8 799
1·25 109·4 86·3 789
2·5 107·8 85·8 794
5·0 108·7 86·6 797
7·5 106·0 84·8 800
10·0 105·8 82·5 781
CLA
No 104·8 83·8 799
Yes 107·6 85·2 792
SED (dose)‡ 2·5 1·8 9·2
SED (CLA)§ 1·9 1·4 7·2
Significance (P )
CLA (linear) 0·60 0·32 0·27
CLA (quadratic) 0·17 0·006 0·21
Control v. CLA 0·17 0·47 0·36
* For details of diets and procedures see Table 1 and p. 220.
† CLA nominally contained 55 % fatty acids as CLA isomers.
‡ SED between different doses of CLA-55 (five per treatment group).
§ SED of the means between diets containing none (no, n 5) and some (yes,
n 25) supplemental CLA-55.
Table 2. Effect of dietary conjugated linoleic acid (CLA) on growth performance of finishing gilts*
(Mean values and standard errors of the difference)
Rate of gain (g/d) Feed intake (g/d)
Feed conversion
efficiency
Time (weeks). . . 0–4 4–8 0–8 0–4 4–8 0–8 0–4 4–8 0–8
Dose of CLA-55 (g/kg)†
0 1024 816 920 3083 3023 3053 0·33 0·28 0·30
1·25 1099 853 976 3062 3079 3070 0·36 0·28 0·32
2·5 1076 870 973 2895 2977 2936 0·37 0·29 0·33
5·0 1067 899 983 2811 2778 2795 0·38 0·32 0·35
7·5 987 851 919 2911 2932 2922 0·34 0·29 0·31
10·0 974 830 902 2677 2758 2717 0·36 0·30 0·33
CLA
No 1024 816 920 3083 3023 3053 0·33 0·28 0·30
Yes 1041 861 951 2871 2905 2888 0·36 0·30 0·33
SED (dose)‡ 84 83 69 197 188 174 0·012 0·025 0·016
SED (CLA)§ 65 65 53 152 146 135 0·009 0·019 0·012
Significance (P )
CLA (linear) 0·19 0·96 0·43 0·04 0·09 0·04 0·36 0·30 0·21
CLA (quadratic) 0·40 0·32 0·26 0·85 0·82 0·82 0·03 0·21 0·07
Control v. CLA 0·80 0·49 0·57 0·18 0·43 0·23 0·006 0·26 0·04
* For details of diets and procedures, see Table 1 and p. 220.
† CLA nominally contained 55 % fatty acids as CLA isomers.
‡ SED between different doses of CLA-55 (five per treatment group).
§ SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemental CLA-55.
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supplementation. However, the deposition rate of ash
tended to increase with increasing levels of dietary CLA
between weeks 4 and 8 only (Table 5). There was no over-
all significant effect on bone deposition rate over the entire
duration of the experiment (P¼0·17).
Chemically determined carcass water composition
increased linearly (P¼0·011) with increasing dietary
supplementation of CLA (Table 6). While there was a
trend towards a linear increase (P¼0·09) in carcass protein
content with increasing CLA, overall difference between
the chemical protein content of control pigs and that of
the CLA pigs was not significant (P¼0·54). Chemically
determined carcass fat decreased linearly (P¼0·008) with
increasing dietary CLA content (Table 6). At the highest
level of CLA inclusion, carcass fat content was decreased
by approximately 43 g/kg (215 %). Carcass ash content
Table 4. Adjusted dual-energy X-ray absorptiometry estimates of fat, lean and ash content of gilts fed dietary conjugated linoleic
acid (CLA)*
(Mean values and standard errors of the difference)
Fat mass (kg) Lean mass (kg) Ash mass (kg)
Time (week). . . 4 8 Carcass 4 8 Carcass 4 8 Carcass
Dose of CLA-55 (g/kg diet)†
0 17·4 25·5 23·0 56·2 67·4 54·5 1·9 2·3 2·0
1·25 18·0 27·8 24·0 56·1 67·4 55·2 1·8 2·4 1·9
2·5 15·4 23·6 20·9 58·1 70·9 58·1 1·7 2·2 1·9
5·0 15·1 23·1 20·1 58·6 70·7 57·7 1·8 2·4 2·0
7·5 15·6 23·5 20·4 57·3 69·3 56·9 1·9 2·4 1·9
10·0 14·1 22·0 18·6 54·7 65·5 53·7 1·8 2·4 1·9
CLA
No 17·4 25·5 23·0 56·2 67·4 54·5 1·9 2·3 2·0
Yes 15·6 24·0 20·8 57·0 68·7 56·3 1·8 2·4 1·9
SED (dose)‡ 1·31 1·84 1·89 1·35 2·26 1·85 0·07 0·09 0·065
SED (CLA)§ 1·02 1·43 1·47 1·04 1·75 1·44 0·05 0·07 0·050
Significance (P )
CLA (linear) 0·007 0·01 0·008 0·41 0·50 0·69 0·78 0·21 0·74
CLA (quadratic) 0·55 0·67 0·67 0·005 0·01 0·009 0·69 0·61 0·62
Control v. CLA 0·09 0·32 0·14 0·46 0·45 0·23 0·53 0·85 0·13
* For details of diets and procedures, see Table 1 and p. 220.
† CLA nominally contained 55 % fatty acids as CLA isomers.
‡ SED between different doses of CLA-55 (five per treatment group).
§ SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemental CLA-55.
Table 5. Effect of dietary conjugated linoleic acid (CLA) determined by dual-energy X-ray absorptiometry on daily deposition
rate of fat, lean and ash in gilts between weeks 0 and 4, 4 and 8 and the overall deposition rates (0–8 weeks)*
(Mean values and standard errors of the difference)
Fat (g/d) Lean (g/d) Ash (g/d)
Time (week). . . 0–4 4–8 0–8 0–4 4–8 0–8 0–4 4–8 0–8
Dose of CLA-55 (g/kg diet)†
0 311 287 299 585 400 493 20·2 17·4 18·8
1·25 319 350 334 631 401 516 20·6 19·7 20·1
2·5 277 294 285 655 456 556 18·1 15·8 17·0
5·0 251 285 268 656 434 545 21·5 20·6 21·0
7·5 267 283 275 606 426 516 21·3 18·5 19·9
10·0 218 281 249 550 385 467 19·7 21·0 20·4
CLA
No 311 287 299 585 400 493 20·2 17·4 18·8
Yes 266 299 282 620 420 520 20·2 19·1 19·7
SED (dose)‡ 30·79 27·43 25·22 43·40 49·00 35·30 1·753 1·984 1·531
SED (CLA)§ 23·85 21·25 19·54 33·60 37·90 27·30 1·358 1·537 1·186
Significance (P )
CLA (linear) 0·002 0·14 0·008 0·18 0·77 0·30 0·68 0·09 0·17
CLA (quadratic) 0·85 0·99 0·91 0·02 0·17 0·02 0·61 0·73 0·95
Control v. CLA 0·07 0·59 0·41 0·32 0·60 0·33 0·98 0·28 0·47
* For details of diets and procedures, see Table 1 and p. 220.
† CLA nominally contained 55 % fatty acids as CLA isomers.
‡ SED between different doses of CLA-55 (five per treatment group).
§ SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemental CLA-55.
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was not affected by dietary CLA. Fat:protein in the carcass
decreased linearly (P¼0·01) with increasing dietary CLA.
There were no significant differences in water:protein in
the carcass.
As expected from the chemically predicted body compo-
sition data, the chemical fat deposition rates determined by
the slaughter-balance technique showed a similar linear
reduction (P¼0·01) with the increasing level of dietary
CLA in the feed (Table 7). At the highest dietary CLA con-
tent, there was an 84 g/d decrease in fat deposition (322 v.
238 g/d). While the effect of dietary CLA supplementation
on chemical protein deposition was variable, there was a
significant quadratic effect ðP ¼ 0·02Þ; with the response
being maximised at a dietary CLA-55 content of 5 g/kg
(Table 7). However, there was no overall difference in
protein deposition rate between control and all CLA-sup-
plemented pigs (138 v. 141 g/d; P¼0·69). Similarly, the
water deposition rate determined by the slaughter-balance
technique showed a quadratic response to the CLA level
supplemented in the diet (P ¼ 0·003; Table 7) with the
response again maximised at 5·0 g CLA-55/kg diet.
There was no effect of dietary CLA on chemical ash
deposition.
The efficacy of using DXA to measure effects of CLA
Table 6. Effect of dietary conjugated linoleic acid (CLA) on chemical carcass composition at week 8 of the treatment*
(Mean values and standard errors of the difference)
Protein (g/kg) Water (g/kg) Water:protein Ash (g/kg) Fat (g/kg) Fat:protein
Dose of CLA-55 (g/kg diet)†
0 159 517 3·26 26·2 293 1·85
1·25 151 516 3·44 25·2 303 2·05
2·5 164 547 3·33 23·7 261 1·61
5·0 168 570 3·39 25·9 232 1·39
7·5 163 545 3·35 25·8 262 1·61
10·0 165 554 3·37 27·1 250 1·52
CLA
No 159 517 3·26 26·2 293 1·85
Yes 162 546 3·38 25·6 261 1·64
SED (dose)‡ 5·9 16·2 0·131 1·36 19·8 0·183
SED (CLA)§ 4·6 12·6 0·102 1·06 15·3 0·142
Significance (P )
CLA (linear) 0·09 0·01 0·71 0·18 0·008 0·01
CLA (quadratic) 0·26 0·04 0·58 0·17 0·06 0·11
Control v. CLA 0·54 0·03 0·24 0·57 0·05 0·14
* For details of diets and procedures, see Table 1 and p. 220.
† CLA nominally contained 55 % fatty acids as CLA isomers.
‡ SED between different doses of CLA-55 (five per treatment group).
§ SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemental CLA-55.
Table 7. Effect of dietary conjugated linoleic acid (CLA) on tissue deposition rates
determined by the slaughter-balance technique at week 8 of the treatment*
(Mean values and standard errors of the difference)
Protein (g/d) Water (g/d) Lean (g/d) Ash (g/d) Fat (g/d)
Dose of CLA-55 (g/kg diet)†
0 138 420 558 19·4 322
1·25 129 428 557 19·7 348
2·5 148 480 627 15·9 285
5·0 153 519 672 19·9 239
7·5 144 471 615 18·8 278
10·0 130 431 561 17·7 238
CLA
No 138 420 558 19·4 322
Yes 141 466 607 18·4 277
SED (dose)‡ 9·8 32·1 39·1 1·72 38·9
SED (CLA)§ 7·6 24·9 30·3 1·33 30·1
Significance (P )
CLA (linear) 0·94 0·47 0·56 0·59 0·01
CLA (quadratic) 0·02 0·003 0·003 0·97 0·41
Control v. CLA 0·69 0·08 0·12 0·46 0·15
* For details of diets and procedures, see Table 1 and p. 220.
† CLA nominally contained 55 % fatty acids as CLA isomers.
‡ SED between different doses of CLA-55 (five per treatment group).
§ SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemental CLA-55.
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on body composition were tested by comparing chemi-
cally determined body composition directly against the
estimates of body composition generated by the internal
algorithms (Table 8). An additional comparison was
then made after the outputs from the DXA machine
were corrected using regression equations relating chemi-
cal composition to DXA estimates generated in a larger
(n 150) group of pigs of varying live weight and body
composition (Suster et al. 2000). The whole animal and
carcass DXA-predicted values for fat, lean and ash com-
pared with those measured on the same animals directly
by chemical analysis were all significantly different
(P,0·001) with fat and ash being underestimated and
lean being overestimated. The greatest differences were
in the live animal estimations of lean, which was probably
due to presence of water in the gut lumen detected as
being associated with lean tissue. Hence, DXA estimation
of lean in the empty body measurement was much closer
to the chemically determined values, although they were
still significantly different (P¼0·002). The DXA predic-
tions adjusted using the regression equations from DXA
validation studies (Suster et al. 2000) essentially corrected
the overestimations and underestimations made by DXA
algorithms. Although whole-body fat and both whole-
body and carcass ash were still significantly different
after correction, the numerical differences were quite
small. The adjusted DXA estimates of carcass fat, lean
and BMC done on the live animal averaged 94·8, 100·4
and 93·6 % of the chemically determined values, respect-
ively, while similar comparisons of DXA estimates deter-
mined on the empty carcass were 99·0, 99·7 and 94·6,
respectively (Table 8).
The correlation (R 0·86) between the fat deposition rate
estimated by the slaughter-balance technique v. the DXA
estimations of fat deposition illustrates that the two
methods are measuring the same thing (Fig. 1). The
slope of the relationship is also close to unity (1·07),
although the intercept is significantly different than zero
indicating a 20 g bias towards the chemical prediction.
Dietary CLA supplementation did not appear to have
any significant effect on the weights of any of the major
internal organs and tissues (Table 9).
Discussion
While there were no significant changes in growth rate as
a result of CLA supplementation, feed intake decreased
in a linear fashion (P¼0·04) as the concentration of CLA
in the diet increased. Consequently, there was a significant
improvement in FCE for CLA-fed pigs (+7·9 %; P¼0·045).
The significant effects in FCE were mostly due to improve-
ments during the first 4 weeks of the treatment interval
where FCE was increased by 8 % (P¼0·006). Other
workers have also observed similar small improvements
in FCE in pigs supplemented with dietary CLA (Dugan
et al. 1997; Thiel-Cooper et al. 2001) and our earlier
work demonstrated that FCE was increased by 6·4 % by
CLA supplementation (Ostrowska et al. 1999).
The present study confirms the findings from our earlier
reports showing that dietary CLA reduces fat deposition
while increasing lean deposition in finisher pigs (Dunshea
et al. 1998; Ostrowska et al. 1999). Using DXA to measure
composition has shown that the response was most
pronounced during the first 4 weeks of CLA supplemen-
tation with very little response thereafter. For example, fat
deposition during the first 4 weeks was minimised at the
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Fig. 1. Correlation between body fat deposition rates determined
by slaughter-balance techniques dual-energy X-ray absorptiometry
(DXA)-predicted fat deposition rates ðY ¼ 1·07X 2 19·6; R 0·86,
P,0·001).
Table 8. Comparison of the final values (week 8) for dual-energy X-ray absorptiometry (DXA), DXA-adjusted
values (DXA-adj) and chemical analysis (CHEM) of body composition*
(Mean values and standard deviations for thirty-five pigs)
CHEM DXA DXAadj† Significance (P )
Variable Mean SD Mean SD Mean SD CHEM v. DXA CHEM v. DXAadj
Chemical analysis of carcass (including viscera) v. DXA live animal estimates
Fat (kg) 25·55 3·94 19·42 2·94 24·23 3·87 ,0·001 ,0·001
Lean (kg) 68·24 4·19 80·57 4·76 68·52 3·95 ,0·001 0·51
BMC (kg) 2·51 0·16 1·81 0·15 2·35 0·17 ,0·001 ,0·001
Chemical analysis of empty carcass v. DXA empty carcass estimates
Fat (kg) 21·38 3·71 18·22 3·00 21·17 3·66 ,0·001 0·51
Lean (kg) 56·20 3·66 59·89 3·53 56·02 3·35 0·002 0·63
BMC (kg) 2·05 0·15 1·72 0·10 1·94 0·11 ,0·001 ,0·001
BMC, bone mineral content.
* For details of procedures, see p. 220.
† DXA values were adjusted using equations from Suster et al. (2000).
Conjugated linoleic acid in pig diets 225
highest level of CLA supplementation, with pigs receiving
10 g CLA-55/kg diet depositing 93 g less fat/d than pigs
fed the unsupplemented diets. However, over the final 4
weeks, fat deposition in the same group of pigs was only
6 g/d less than that of control pigs. Despite this, the combi-
nation of large differences in fat deposition rates over the
first 4 weeks of feeding with much smaller differences
during the following weeks of CLA supplementation still
resulted in an overall significant decrease in fat deposition.
At the end of the experiment, pigs fed the highest level of
CLA averaged 50 g/d less fat accretion than control pigs
(P¼0·008). In a previous experiment, the reduction in fat
deposition rate at the highest level of supplementation
(10 g/kg) was found to be much greater (286 g/d;
Ostrowska et al. 1999). However, in the latter study the
fat deposition rates were determined from the difference
in body composition found in pig carcasses at the end of
the experiment compared with a representative group of
pigs slaughtered at the beginning of the experiment (slaugh-
ter-balance technique). The present study also provided a
very similar estimate of reduction in fat deposition when
estimated using the slaughter-balance technique (284 g/d).
However, there is a very high internal consistency in fat
deposition responses both between studies using the same
technique and within a study using different techniques
(Fig. 1).
The DXA-determined lean deposition rates were maxi-
mised during the first 4 weeks (0–4 weeks) of dietary
CLA supplementation with no significant effects being
observed in the subsequent 4 weeks (4–8 weeks) of the
study. The DXA-determined lean tissue deposition rates
were maximised at between 2·5 and 5·0 g CLA-55/kg
diet, similar to that observed by Ostrowska et al. (1999).
The chemical analyses in the present study, as well as
our earlier work (Ostrowska et al. 1999), indicate that
there was very little change in protein deposition, and
that the change in lean tissue was due predominantly to
an increase in water deposition. Since DXA technology
estimates lean tissue from body water content, an increase
in tissue hydration will be ascribed to an increase in lean
tissue. Although there was no significant effect of CLA
on water:protein in the present study, previously we have
shown a significant increase in water:protein of a similar
magnitude to that observed here (Ostrowska et al. 1999).
Therefore, some care should be made in interpreting
DXA-determined changes in body composition when
there are also resultant changes in tissue hydration. It is
also worth noting that the lean tissue deposition response
to CLA supplementation was quadratic, being maximised
at between 2·5 and 5·0 g CLA-55/kg, whereas the fat depo-
sition response was linear. The different dose responses to
CLA will need to be taken into account when determining
the most cost-effective dose to feed on-farm.
The genotype used in the present study and that of
Ostrowska et al. (1999) was of moderate fatness and gilts
were utilised in these studies as they tend to deposit
more fat than boars (Dunshea et al. 1993). However, the
responses to CLA may vary with genetic propensity for
fat or lean accretion. CLA response may also vary between
gilts and barrows. For example, the benefits of a similar
CLA preparation to that used in the present study appeared
to be less pronounced in lean genotypes, as was observed
in an on-farm study with boars and gilts (Dunshea et al.
2002). Also, the response varied between farms and/or
genotypes and was greater in gilts than in boars (Dunshea
et al. 2002). However, smaller but significant reductions
in carcass P2 (21·0 mm) and carcass fat (27 g/kg) were
recorded under commercial conditions at dietary CLA
Table 9. Effect of dietary conjugated linoleic acid (CLA) on visceral organ weights at week 8 of the treatment*
(Mean values and standard errors of the difference)
Weight (g)
Organ. . . Liver Heart Kidneys Lungs Stomach Small intestine Caecum Large intestine Spleen
Dose of CLA-55 (g/kg diet)†
0 1757 333 339 630 601 1377 220 1851 154
1·25 1743 337 302 535 570 1282 199 1558 134
2·5 1814 346 326 554 597 1316 226 1693 160
5·0 1782 380 360 536 553 1279 221 1828 143
7·5 1880 366 338 669 561 1230 196 1600 130
10·0 1718 353 353 577 542 1214 207 1669 146
CLA
No 1757 333 339 630 601 1377 220 1851 154
Yes 1787 356 336 574 565 1264 210 1670 142
SED (dose)‡ 111 20·7 24·2 85·6 41·7 104 24·3 157 15·6
SED (CLA)§ 86 16·0 18·7 66·3 32·3 80 18·8 121 12·1
Significance (P )
CLA (linear) 0·86 0·12 0·13 0·70 0·15 0·12 0·53 0·55 0·45
CLA (quadratic) 0·29 0·09 0·93 0·64 0·86 0·81 0·82 0·91 0·62
Control v. CLA 0·73 0·17 0·89 0·41 0·27 0·18 0·59 0·15 0·37
* For details of diets and procedures, see Table 1 and p. 220.
† CLA nominally contained 55 % fatty acids as CLA isomers.
‡ SED between different doses of CLA-55 (five per treatment group).
§ SED of the means between diets containing none (no, n 5) and some (yes, n 25) supplemental CLA-55.
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concentrations as little as 2·2 g total CLA/kg. A recent
short communication (Heckart et al. 2000) reported that
feeding CLA decreased expression of fatty acid synthase
in medium-lean line pigs and increased (P,0·01)
expression in the high-lean pigs. The expression of stear-
oyl-CoA desaturase was decreased (P,0·01) in medium-
lean line pigs and tended (P¼0·08) to increase in the
high-lean line group. These data suggest that CLA acts
to modify expression of lipogenic genes in pigs that
have not been selected for low fat deposition rates
(Heckart et al. 2000). Furthermore, others have shown
that supplementation of CLA does not alter backfat thick-
ness in lactating sows (Harrell et al. 2000; Poulos et al.
2000). Therefore, it is possible that there are differences
between the adolescent and adult animals and their
response to CLA. There are data to suggest that CLA
may affect growing animals differently from adults by
depressing body fat accumulation via a reduction in pre-
adipocyte number when given during periods of growth
(Satory & Smith, 1999). In human studies, with weight-
stable adults with stable body composition, no reduction
in fat content was observed as a result of CLA (65 %
purity) supplementation at 3 g/d (Medina et al. 2000; Zam-
bell et al. 2000). However, a study with obese or over-
weight volunteers reported significant reductions in body
fat at levels of 3·4 and 6·8 g CLA (75 % purity)/d (Blank-
son et al. 2000) and significant reductions in abdominal
fat at 4 g CLA (75 % purity)/d (Riserus et al. 2001). If
CLA does not stimulate lipolysis then one would expect
to see no reduction in body fat already present in weight-
stable adults. However, if it worked by inhibiting fat accre-
tion, then CLA would work in adults providing they exer-
cised or dieted so that the CLA could inhibit regain of fat.
Data from our previous study in a pig model showed that
the reduced fat accretion in pigs fed CLA was largely
attributed to a reduced rate of lipogenesis from preformed
fatty acids and possibly to a lesser extent due to increased
lipolysis (Ostrowska et al. 2002).
The isomer thought to be responsible for the reduction in
lipid accretion and storage in laboratory animals is the trans,
cis-10,12; (de Deckere et al. 1999; Park et al. 1999a). This
isomer was the most predominant in the CLA mixture used
in the present study. The trans, cis-10,12 isomer was found
to affect key enzymes involved in fatty acid uptake and trans-
port. Some of the responses included a reduction in lipopro-
tein lipase activity, and lower levels of triacylglycerol and
glycerol in adipocyte cells (Lin et al. 1999; Park et al.
1999b; Wang et al. 1999). Recently, the isomer was shown
to markedly reduce the expression of genes encoding for
two key enzymes, acetyl CoA carboxylase and fatty acid
synthetase, involved in de novo fatty acid synthesis in
dairy cows (Baumgard et al. 2002). Furthermore, the
expression encoding for the enzyme that hydrolyses circulat-
ing triacylglycerol (lipoprotein lipase) as well as proteins
involved in intracellular trafficking of fatty acids (fatty
acid-binding protein) were also significantly reduced
(Baumgard et al. 2002).
Further additional information gained from the present
study was the effect of CLA on BMC and density. In
recent studies with chicks and rats, CLA was shown to
increase the rate of bone formation as indicated by an
increase in percentage of ash in the body (Li & Watkins,
1998; Park & Pariza, 1998; de Deckere et al. 1999; Wat-
kins & Seifert, 2000). In the present study, dietary CLA
supplementation had no effect on the rate of ash deposition
as determined by the slaughter-balance technique. The
DXA estimates of bone density and content, both of
which are free from assumptions regarding levels of
tissue hydration (Haderslev et al. 1999), confirmed that
CLA had little effect on these measures in pigs.
Despite widespread use of non-esterified fatty acid or
methyl ester forms of CLA in research diets there is no
evidence of the differences in the digestibility of different
preparations. Non-esterified fatty acids are known to be
less digestible in pigs when compared with triacylglycerols
(Whittemore, 1993). Therefore the reduction in the feed
intake in the CLA-fed pigs could be partially attributed to
the acceptability of non-esterified fatty acids as lipid
source. However, the growth rate was unaffected by CLA
supplementation indicating that CLA non-esterified fatty
acids were digested and metabolised sufficiently to maintain
growth. Furthermore, the CLA was assimilated very effi-
ciently into the tissue of pigs and in a dose-dependent
manner (E Ostrowska, unpublished results). Today, the com-
mercially available CLA is present in methyl esters of fatty
acids. Lipids in this form are not found in natural diets and it
is possible that esterified fatty acids could be less digestible
than triacylglycerols or even non-esterified fatty acids. The
ability of pigs to digest and assimilate these different
forms of CLA needs to be more thoroughly investigated.
In conclusion, use of DXA technology has shown that
the greatest reductions in fat deposition rates and increase
in lean tissue deposition rates were achieved in the initial
4 weeks of CLA supplementation. This in turn suggests
that the small additional benefits from long-term feeding
with CLA may not necessarily be cost-effective.
Additional factors including genetics, sex and age of the
animal and the CLA isomer composition and its form prob-
ably play a vital role in determining the final outcome.
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